MediFind
Condition

Giant Cell Arteritis

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Large Vessel Vasculitis
  • Journal: Current rheumatology reports
  • Treatment Used: Long-Term Glucocorticoid Treatment
  • Number of Patients: 0
  • Published —
The study researched the safety of long-term glucocorticoid treatment for large vessel vasculitis.
Latest Advance
Study
  • Condition: Giant Cell Arteritis and Takayasu Arteritis
  • Journal: Current rheumatology reports
  • Treatment Used: Methotrexate
  • Number of Patients: 0
  • Published —
The study researched the outcomes of treatment for giant cell arteritis and all patients with Takayasu arteritis.
Latest Advance
Study
  • Condition: Giant Cell Arteritis (GCA)
  • Journal: Current opinion in rheumatology
  • Treatment Used: Tocilizumab
  • Number of Patients: 0
  • Published —
This article addresses new development in the diagnosis and management of giant cell arteritis (GCA).
Latest Advance
Study
  • Condition: Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient with Hypereosinophilic Syndrome
  • Journal: Internal medicine (Tokyo, Japan)
  • Treatment Used: Low-dose corticosteroid
  • Number of Patients: 0
  • Published —
The study researched the outcomes of eosinophilic temporal arteritis and digital ischemia in a patient with hypereosinophilic syndrome.
Latest Advance
Study
  • Condition: Rheumatic Disease
  • Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
  • Treatment Used: Corticosteroid Tapering Regimens
  • Number of Patients: 62
  • Published —
This review of the literature assessed clinical outcomes of differing tapering regimens after corticosteroid monotherapy in adults with rheumatic disorders.
Latest Advance
Study
  • Condition: Large Vessel Vasculitis
  • Journal: Rheumatology (Oxford, England)
  • Treatment Used: Tocilizumab
  • Number of Patients: 12
  • Published —
This study evaluated the effectiveness and safety of tocilizumab therpay for large vessel vasculitis.
Latest Advance
Study
  • Condition: Aortitis Disease
  • Journal: The heart surgery forum
  • Treatment Used: Aortic Valve Surgery
  • Number of Patients: 15
  • Published —
The study researched the outcomes of aortic valve surgery in patients with aortitis disease.
Latest Advance
Study
  • Condition: Glucocorticoid Resistant Refractory Giant Cell Arteritis
  • Journal: BMJ case reports
  • Treatment Used: intravenous tocilizumab
  • Number of Patients: 1
  • Published —
The purpose of the study was to report a case of a patient with glucocorticoid resistant refractory giant cell arteritis treated with intravenous tocilizumab.
Latest Advance
Study
  • Condition: Large-vessel vasculitis giant cell arteritis (GCA) and Takayasu arteritis (TA)
  • Journal: Der Internist
  • Treatment Used: Tocilizumab (TCZ)
  • Number of Patients: 0
  • Published —
This study described the necessary diagnostic testing and rapid treatment approaches for patients diagnosed with large-vessel vasculitis -- giant cell arteritis (GCA) and Takayasu arteritis (TA) --
Latest Advance
Study
  • Condition: Scleritis
  • Journal: Ocular immunology and inflammation
  • Treatment Used: Tocilizumab
  • Number of Patients: 1
  • Published —
This case report discusses a 62-year-old Caucasian female diagnosed with scleritis and giant cell arteritis (GCA) treated with topical and systemic NSAIDs, prednisone and diverse disease-modifying antirheumatic drugs and tocilizumab.
Latest Advance
Study
  • Condition: Giant Cell Arteritis
  • Journal: International journal of rheumatic diseases
  • Treatment Used: Glucocorticoid Therapy
  • Number of Patients: 14
  • Published —
This study tested the safety and efficacy of using glucocorticoid therapy to treat patients with giant cell arteritis.
Latest Advance
Study
  • Condition: Giant Cell Arteritis
  • Journal: Rheumatology (Oxford, England)
  • Treatment Used: Tocilizumab Therapy
  • Number of Patients: 20
  • Published —
This study evaluated the incidence of relapse after discontinuing tocilizumab therapy in patients with giant cell arteritis (inflammation of the lining of the arteries).